IP
CLDX icon

Intellectus Partners’s Celldex Therapeutics CLDX Stock Holding History

Intellectus Partners’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-266
Closed -$1K – 216
2019
Q1 		$1K Buy
+266
New +$1.4K ﹤0.01% 421
2018
Q4 		– Sell
-267
Closed -$2K – 297
2018
Q3 		$2K Hold
267
– – ﹤0.01% 554
2018
Q2 		$2K Hold
267
– – ﹤0.01% 562
2018
Q1 		$9K Hold
267
– – ﹤0.01% 483
2017
Q4 		$11K Hold
267
– – ﹤0.01% 468
2017
Q3 		$11K Hold
267
– – ﹤0.01% 605
2017
Q2 		$10K Hold
267
– – ﹤0.01% 592
2017
Q1 		$14K Hold
267
– – 0.01% 499
2016
Q4 		$14K Buy
+267
New +$15.2K 0.01% 486

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return